Organic compounds -- part of the class 532-570 series – Organic compounds – Nitrogen attached directly or indirectly to the purine ring...
Patent
1994-08-11
1997-05-20
Burn, Brian M.
Organic compounds -- part of the class 532-570 series
Organic compounds
Nitrogen attached directly or indirectly to the purine ring...
C07C24136
Patent
active
056313730
ABSTRACT:
Methods of treating or preventing neuronal loss associated with stroke, ischemia, CNS trauma, hypoglycemia, and surgery, as well as treating neurodegenerative diseases including Alzheimer's disease, amyotrophic lateral sclerosis, Huntington's disease, and Down's syndrome, treating or preventing the adverse consequences of the hyperactivity of the excitatory amino acids, as well as treating anxiety, chronic pain, convulsions, and inducing anesthesia are disclosed by administering to an animal in need of such treatment an alkyl or azido-substituted 1,4-dihydroquinoxaline-2,3-dione or pharmaceutically acceptable salts thereof, which have high binding to the glycine receptor.
REFERENCES:
patent: 3962440 (1976-06-01), St. Clair et al.
patent: 3992378 (1976-11-01), St. Clair et al.
patent: 4659713 (1987-04-01), Hass
patent: 4803270 (1989-02-01), Takemoto
patent: 4812458 (1989-03-01), Honor e et al.
patent: 4889855 (1989-12-01), Jacobsen et al.
patent: 4948794 (1990-08-01), Honore et al.
patent: 4975430 (1990-12-01), Jahr et al.
patent: 4977155 (1990-12-01), Jacobsen et al.
patent: 5026704 (1991-06-01), Honore et al.
patent: 5055465 (1991-10-01), Davey
patent: 5057516 (1991-10-01), Jacobsen et al.
patent: 5061706 (1991-10-01), Honore e et al.
patent: 5081123 (1992-01-01), Honor e et al.
patent: 5166155 (1992-11-01), Jorgensen et al.
patent: 5196421 (1993-03-01), McQuaid et al.
patent: 5268378 (1993-12-01), Baker et al.
patent: 5283244 (1994-02-01), Sakamoto et al.
patent: 5308845 (1994-05-01), Honor e et al.
patent: 5352683 (1994-10-01), Mayer et al.
Adreasen et al., "Effects of Non-N-Methyl-D-Aspartate Antagonists on Synaptic Transmission in the In Vitro Rat Hippocampus," J. Physiol. 414:317-336 (1989).
Bigge, C., "Structural Requirements for the Development of Potent N-Methyl-D-Aspartic Acid (NMDA) Receptor Antagonists," Biochem. Pharm. 45:1547-1561 (1993).
Birch et al., "FG-9065 and FG-9041 antagonise responses to NMDA via an action at the strychnine-insensitive glycine receptor," Meeting of the British Pharmacological Society, Nottingham, England, Sep. 7-9, 1988, Br. J. Pharmacol. 95:758P (1988).
Carling et al., "Anticonvulsant Activity of Glycine-site NMDA Antagonists," Bioorganic & Medicinal Chem. Lett. 3:65-70 (1993).
Carling et al., "3-Nitro-3,4-dihydro-2(1H)-quinolones. Excitatory Amino Acid Antagonists Acting at Glycine-Site NMDA and (RS)-.alpha.-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptors," J. Med. Chem. 36:3397-3408 (1993).
Cheeseman, G. W. H., "Quinoxalines and Related Compounds, Part VI. Substitution of 2,3-Dihydroxyquinoxaline and its 1,4-Dimethyl Derivative," J. Chem. Soc. 223:1170-1176 (1962).
Davies & Collingridge, "Quinoxalinediones as Excitatory Amino Acid Antagonists in the Vertebrate Central Nervous System," Int. Rev. Neurobiol. 32:281-303 (1990).
Drejer, J. and Honor e, T., "New quinoxalinediones show potent antagonism of quisqualate responses in cultured mouse cortical neurons," Neuroscience Lett. 87:104-108 (1988).
Epperson et al., "Synthesis and Excitatory Amino Acid Pharmacology of Some Novel Quinoxalinediones," Bioorganic & Medicinal Chem. Lett. 3(12):2801-2804 (1993).
Fletcher, E. J. and Lodge, D., "Glycine reverses antagonism of N-methyl-D-aspartate (NMDA) by 1-hydroxy-3-aminopyrrolidone-2 (HA-966) but not by D-2-amino-5-phophonovalerate (D-AP5) on rat cortical slices," Eur. J. Pharmacol. 151:161-162 (1988).
Fletcher et al., "Quinoxalinediones selectively block quisqualate and kainate receptors and synaptic events in rat neocortex and hippocampus and frog spinal cord in vitro," Br. J. Pharmacol. 95:585-597 (1988).
Frandsen et al., "Direct Evidence That Excitotoxicity in Cultured Neurons Is Mediated via N-Methyl-D-Aspartate (NMDA) as well as Non-NMDA Receptors," J. Neurochem. 53(1):297-299 (1989).
Frenk et al., "Absence of Side-Effects in the Anticonvulsant Action of Cortically Applied Antagonists of N-Methyl-D-Aspartate," Brain Res. 373:222-226 (1986).
Hays et al., "N-Sulfonyl Derivatives of 6,7-Dichloro 3,4-Dihydro-3-Oxo-quinoxalinecarboxylate as Glycine-site NMDA and AMPA Antagonists," Bioorg. & Med. Chem. Lett. 3:77-80 (1993).
Honor e et al., "Quinoxalinediones: Potent Competitive Non-NMDA Glutamate Receptor Antagonists," Science 241:701-703 (1988).
Honor e et al., "Quinoxalinediones. Non-N-Methyl-D-Aspartate Receptor Antagonists as Potential Drug Candidates," in: Excitatory Amino Acids, Meldrum et al., eds., Raven Press, Ltd., New York, pp. 451-460 (1991).
Honor e et al., "Preparation and testing of 2,3(1H,4H)-qionoxalinediones as neuroleptics," Chem. Abtr. 111:232859a (1989).
Honor e et al., "Preparation and use of neuroleptic quinoxaline compounds," Chem. Abtr. 114:81885q (1990).
Horner et al., "Derivatives of quinoxaline as isosteres of the pteridines," Chem. Abstracts 48:2692-2693 (1953).
Joergensen et al., "Preparation of 1-carboxyalkyl-2,3-dioxoquinoxalines as glycine antagonists," Chem. Abtr. 115:280059u (1991).
Kay & Ikeda, "The quinoxalinediones antagonise the visual firing of sustained retinal ganglion cells," Eur. J. Pharmacol. 164:381-384 (1989).
Kemp & Leeson, "The glycine site of the NMDA receptor-five years on," TiPs 14:20-25 (Jan. 1993).
Kessler et al., "Quinoxaline derivatives are high-affinity antagonists of the NMDA receptor-associated glycine sites," Brain Res. 489:377-382 (1989).
Kessler et al., "A Glycine Site Associated with N-Methyl-D-Aspartic Acid Receptors: Characterization and Identification of a New Class of Antagonists," J. Neurochem. 52:1319-1328 (1989).
Kleckner, N.W. and Dingledine, R., "Selectivity of Quinoxalines and Kynurenines as Antagonists of the Glycine Site on N-Methyl-D-aspartate Receptors," Molec. Pharmacol. 36:430-436 (1989).
Kulagowski et al., "3'-(Arylmethyl)-and 3'-(Aryloxy)-3-phenyl-4-hydroxyquinolin-2(1H)-ones: Orally Active Antagonists of the Glycine Site on the NMDA Receptor," J. Med. Chem. 37(10):1402-1405 (1994.
Leeson et al., "Amino Acid Bioisosteres: Design of 2-Quinolone Derivatives as Glycine-Site N-Methyl-D-aspartate Receptor Antagonists," Bioorg. & Med. Chem. Lett. 3:299-304 (1993).
Leeson and Iversen, "The Glycine site on the NMDA Receptor: Structure-Activity Relationships and Therapeutic Potential," J. Med. Chem. 37:4053-4067 (1994).
Leeson, P.D., "Glycine-Site N-Methyl-D-Aspartate Receptor Antagonists," Drug Design for Neuroscience, A.P. Kozikowski, ed., Raven Press, Ltd., New York, pp. 339-381 (1993).
Leeson et al., "Kynurenic Acid Derivatives. Structure-Activity Relationships for Excitatory Amino Acid Antagonism and Identification of Potent and Selective Antagonists at the Glycine Site on the N-Methyl-D-Aspartate Receptor," J. Med. Chem. 34(4):1243-1252 (1991).
Lester et al., "Interaction of 6-Cyano-7-nitroquinoxaline-2,3-dione with the N-Methyl-D-aspartate Receptor-Associated Glycine Binding Site," Molecular Pharmacol. 35:565-570 (1989).
Littman et al., "The quinoxalinediones DNQX, CNQX and two related congeners suppress hair cell-to-auditory nerve transmission," Hearing Res. 40:45-53 (1989).
Lodge & Jones, "Evidence for Glutamate Receptor Subtypes From In Vivo Electrophysiology: Studies with HA-966, Quinoxalinediones and Philanthotoxin," pp. 101-108 in:Excitatory Amino Acids and Neuronal Plasticity, Ben-Ari, Y. (ed.), Plenum Press, New York (1990).
Lodge et al., "Excitatory amino acids:new tools for old stories or Pharmacological subtypes of glutamate receptors:electrophysiological studies," Can. J. Physiol. Pharmacol. 69:1123-1128 (1991).
Louvet et al., "Novel benzimidazoles as ligands for the strychnine-insensitive N-methyl-D-aspartate-linked glycine receptor," Eur. J. Med. Chem. 28:71-75 (1993).
Lufty et al., "Inhibition of clonic seizure-like excitatory effects induced by intrathecal morphine using two NMDA receptor antagonists: MK-801 and ACEA-1011," Eur. J. Pharmacol. 252:261-266 (1994).
Lufty et al., "Analgesia-Induced by Morphine and ACEA-1011, A Novel Glycine/NMDA Receptor Antagonist in the Formalin Test in Mice Selectively Bred for High and Low Swim-Induced Analgesia," abstract no. 3646, FASEB Journal 8(4-5):A629 (1994).
Matsumoto et al., "AMPA and NMDA Recep
Cai Sui X.
Keana John F.W.
Kher Sunil
Weber Eckard
ACEA Pharmaceuticals, Inc.
Burn Brian M.
State of Oregon acting by and through the Oregon State Board of
The Regents of the University of California
LandOfFree
Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxali does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxali, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxali will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1724856